Efficacy of DE-MRI-Guided Fibrosis Ablation vs. Conventional Catheter Ablation of Atrial Fibrillation: The DECAAF II Study

  • STATUS
    Enrolling By Invitation
Updated on 19 February 2024

Summary

You are being asked to participate in this study because you have atrial fibrillation and are planning to undergo an ablation procedure to treat this heart rhythm irregularity.

Description

Atrial fibrillation (AF) is a condition of the heart that consists of disorganized electrical activity involving the entire atria (upper chambers) of the heart. AF is more prevalent with advancing age and is associated with structural heart disease including high blood pressure, systolic and diastolic ventricular dysfunction (dysfunction of the lower heart chambers), and disease of the heart valves. It represents a significant public health problem in the general population around the world. People with AF are more likely to have a stroke, a diminished quality of life, and a greater chance of heart failure or other conditions of the heart. Research has shown that people with AF have scarring or some amount of damaged tissue in their heart’s upper chamber. This scarred tissue can determine whether AF continues or whether it can be stopped. The more fibrosis, or scar tissue, that is present in the atrium, the more likely it is for the arrhythmia to continue. While conventional catheter ablation has been successful for rhythm control in AF, the success of this procedure is significantly affected by the amount of scar tissue at the time of catheter ablation. Some doctors target specific areas of the fibrotic or scarred tissue in addition to the regular ablation procedure. This type of ablation uses images of the fibrotic areas on your heart to help target the fibrosis, (scarred areas), during the ablation procedure.

FAQ


Details
Condition atrial ablation
Age 18years - 60years
Clinical Study IdentifierTX6313
Last Modified on19 February 2024

Eligibility

If you need help finding a study or have any questions, please contact us at psom-ocr@pobox.upenn.edu

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.